The FTC said Surmodics and Biocoat are, respectively, the largest and second-largest provider of the coatings. GTCR's acquisition of Surmodics...
3 months ago

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance · Total Revenue of $28.1...
1 month ago

AG Ellison Joins Suit to Block Surmodics Acquisition. Minnesota's attorney general says that Surmodics' plan to get acquired by a Chicago-based...
2 months ago

Total revenue decreased $0.6 million, or 2%, to $29.9 million, compared to $30.6 million in the first quarter of fiscal 2024.
4 months ago

Surmodics, a Twin Cities medtech firm with fewer than 400 employees, is a bite-sized operation compared with companies recently scrutinized...
1 month ago

Surmodics projects 162.5% growth for fiscal 2025 and expects to maintain its strong performance going forward.
3 months ago

“Medical device makers rely on high-quality coatings in designing and bringing to market life-saving devices, such as neurovascular catheters,”...
3 months ago

The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' acquisition by private equity firm GTCR...
3 months ago

Under the terms of the merger agreement, an affiliate of GTCR will acquire all outstanding shares of Surmodics. Surmodics shareholders will...
3 months ago

“Assuming that the deal does not happen (our Bear Case), we now estimate that SRDX shares are worth ~$21 which is based on an EV/sales multiple...
1 month ago